<DOC>
	<DOCNO>NCT02391402</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy Cognitively Augmented Behavioral Activation ( CABA ) , new hybrid treatment Veterans diagnose comorbid mild Traumatic Brain Injury ( mTBI ) posttraumatic stress disorder ( PTSD ) . The study 's specific goal determine whether : 1 ) CABA reduce PTSD symptom Veterans mTBI/PTSD , 2 ) CABA reduce cognitive-related functional impairment Veterans mTBI/PTSD , 3 ) CABA result improvement depression symptom , cognitive functioning , quality life Veterans mTBI/PTSD ; 4 ) CABA acceptable treatment Veterans mTBI/PTSD . The overall goal develop evidence-based manualized treatment comorbid mTBI/PTSD readily implement Veterans Health Administration ( VHA ) treatment setting .</brief_summary>
	<brief_title>Cognitively Augmented Behavioral Activation Veterans With Comorbid TBI/PTSD</brief_title>
	<detailed_description>Veterans historically exhibit high rate comorbid mTBI/PTSD . Given comorbidity neuropsychiatric symptom overlap disorder , difficult determine whether problem disruption function due mTBI , PTSD , . Hence , challenge provider know prioritize patient ' clinical issue effectively treat . Currently , evidence-based treatment comorbid mTBI/PTSD . Further , unclear extent exist treatment disorder adherently effectively implement . As , current treatment recommendation suggest holistic integrated approach treatment comorbid mTBI/PTSD target symptom functionality rather underlying etiology . Investigators propose treatment comorbid mTBI PTSD directly target daily function quality life . The study design make use convergent availability resource two participate Veterans Administration Health Care Systems Portland , Oregon , Seattle , Washington conduct Randomized Controlled Trial ( RCT ) CABA . The study recruit total 192 Veterans less equal 55 year age , 96 participant site , enrol participate VA Medical Centers ( VAMCs ) diagnose mTBI PTSD . Eligible participant randomly assign either CABA Treatment Usual ( TAU ) group . Participants CABA group receive CABA intervention first 14 week participation study , whereas TAU participant continue receive TAU ( usual care PTSD specialty treatment clinic , CABA ) participation study . Both group undergo evaluation baseline , 7 week ( mid-treatment ) , 14 week ( post-treatment ) , 39 week ( 6 month follow-up ) . During study participation , participant continue receive usual medical care .</detailed_description>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<criteria>Veterans 55 year age enrol participate VA site able provide inform consent . Diagnosis PTSD base Clinician Administered PTSD Scale . Positive screen Structured Interview Collecting Head Trauma Event Characteristics per VA/Department Defense ( DoD ) Clinical Practice Guideline Management Concussion/mTBI ; AND endorse Neurobehavioral Symptom Inventory ( NSI ) cognitive symptom item ( item 1317 ) . English speaking , able travel primary care clinic weekly 10 session followup assessment , willing refrain initiation additional mental health treatment first 3 1/2 month active phase treatment assign CABA condition . Willingness participate audiorecorded session . ( treatment adherence ) Current diagnosis moderate severe substance ( alcohol ) use disorder use DSM5 criterion within past 30 day . Individuals psychiatric diagnosis exclude except bipolar disorder psychotic disorder ( requirement refrain additional treatment might harmful ) . Veterans history indicate medical record review diagnosis moderate , severe , penetrate TBI , selfreported history Structured Interview Collecting Head Trauma Event Characteristics TBI PostTraumatic Amnesia ( PTA ) great 24 hour loss consciousness ( LOC ) great 30 minute . Active suicidal intent indicate significant clinical risk , would suggest treatment specifically target intent indicate . Clients report suicidal ideation without imminent risk admit study . Initiated psychotropic medication , include Prazosin , within 4 week change dosage within 2 week prior first assessment , would make difficult determine treatment contribute change CABA condition ; additionally , start change dosage sleep medication low dosages tricyclic antidepressant trazodone pain sleep within 1 week prior first assessment . Participants could reconsider eligibility stability medication achieve . Enrollees ask hold dos current medication stable course enrollment ( though change medication enrollment exclude ongoing participation ) . Auditory visual impairment would compromise ability participate benefit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Brain injury</keyword>
	<keyword>TBI</keyword>
	<keyword>PTSD</keyword>
	<keyword>Polytrauma</keyword>
</DOC>